(Q40840566)

24 September 2017

Activation of the alternative pathway of human complement by autologous cells expressing transmembrane recombinant properdin (English)

1 reference

24 September 2017

transmembrane protein

0 references

author name string

Vuagnat BB

series ordinal

1

1 reference

PubMed ID

11090881

24 September 2017

Mach J

series ordinal

2

1 reference

PubMed ID

11090881

24 September 2017

Le Doussal JM

series ordinal

3

1 reference

24 September 2017

1 June 2000

1 reference

24 September 2017

1 reference

24 September 2017

37

1 reference

24 September 2017

8

1 reference

24 September 2017

467-478

1 reference

Computer calculation of multiple binding equilibrium isotherms: application to the binding of bivalent ligands to antibodies interacting with cell surface Fc-receptors.

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900069-9

7 January 2021

Complement component C3 fixes selectively to the major outer membrane protein (MOMP) of Legionella pneumophila and mediates phagocytosis of liposome-MOMP complexes by human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900069-9

7 January 2021

CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900069-9

7 January 2021

The effect of cell size and receptor density on ligand-receptor reaction rate constants

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900069-9

7 January 2021

Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900069-9

7 January 2021

Resolution and analysis of 'native' and 'activated' properdin

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900069-9

7 January 2021

Analysis of the interactions between properdin, the third component of complement (C3), and its physiological activation products

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900069-9

7 January 2021

Dependence of germinal center B cells on expression of CD21/CD35 for survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900069-9

7 January 2021

Cloning and expression of a cDNA coding for the human platelet-derived growth factor receptor: evidence for more than one receptor class

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900069-9

7 January 2021

Transfecting mammalian cells: optimization of critical parameters affecting calcium-phosphate precipitate formation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900069-9

7 January 2021

Complement killing of human neuroblastoma cells: a cytotoxic monoclonal antibody and its F(ab')2-cobra venom factor conjugate are equally cytotoxic

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900069-9

7 January 2021

Complement recruitment using bispecific diabodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900069-9

7 January 2021

Mechanism of action of factor D of the alternative complement pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900069-9

7 January 2021

Activation of the alternative pathway of complement by monoclonal lambda light chains in membranoproliferative glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900069-9

7 January 2021

The molecular basis of target cell killing by human lymphocytes and of killer cell self-protection

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900069-9

7 January 2021

Molecular cloning of the cDNA coding for properdin, a positive regulator of the alternative pathway of human complement

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900069-9

7 January 2021

Characterization of the human properdin gene

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900069-9

7 January 2021

The C3 convertase of the alternative pathway of human complement. Enzymic properties of the bimolecular proteinase

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900069-9

7 January 2021

A monoclonal antibody which blocks the function of factor D of human complement

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900069-9

7 January 2021

Inhibition of complement alternative pathway in mice with Fab antibody to recombinant adipsin/factor D

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900069-9

7 January 2021

The macrophage-attachment glycoprotein gp63 is the predominant C3-acceptor site on Leishmania mexicana promastigotes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900069-9

7 January 2021

Specificity of the thioester-containing reactive site of human C3 and its significance to complement activation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900069-9

7 January 2021

Covalent binding of C3b to monoclonal antibodies selectively up-regulates heavy chain epitope recognition by T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900069-9

7 January 2021

Assembly of the cytolytic alternative pathway of complement from 11 isolated plasma proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900069-9

7 January 2021

Antibody-independent activation of the alternative complement pathway by measles virus-infected cells

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900069-9

7 January 2021

HIV and HIV-infected cells differentially activate the human complement system independent of antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900069-9

7 January 2021

Covalent linkage of C3 to properdin during complement activation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900069-9

7 January 2021

10.1016/S0161-5890(00)00069-9

Identifiers

DOI

1 reference

24 September 2017

1 reference

PubMed ID

11090881